Research map: Lentinan Attenuates Experimental Atherosclerosis by Regulating Macrophage HCK/GUSB Expression and Amino Acid Metabolic Remodeling

Back to the article

Papers in this map

  1. The changing landscape of atherosclerosis · Peter Libby · 2021 · 2895 citations · Cited by this paper
  2. Beyond Branch Patency: Timing, Bleeding Phenotype, and Organ Risk in Antithrombotic Therapy After Branched EVAR · 2026 · Related
  3. The Global Burden of Cardiovascular Diseases and Risk · Muthiah Vaduganathan · 2022 · 2252 citations · Cited by this paper
  4. Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction · 2026 · Related
  5. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities · Magnus Bäck · 2019 · 1342 citations · Cited by this paper
  6. Guideline-directed Low-density Lipoprotein Cholesterol Management After Acute Coronary Syndrome in Patients With Mental Illness: a Population-based Study · 2026 · Related
  7. The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation · Anastasia Vladimirovna Poznyak · 2020 · 1187 citations · Cited by this paper
  8. Reflections on Oral Beta Blocker Therapy and Long-term Outcomes after Myocardial Infarction in Preserved Left Ventricular Function · 2026 · Related
  9. Targeting inflammation in atherosclerosis — from experimental insights to the clinic · Oliver Soehnlein · 2021 · 1027 citations · Cited by this paper
  10. Sennoside A Ameliorates Myocardial Fibrosis After Myocardial Infarction by Binding to KDM4B and Regulates IRX2 Expression · 2026 · Related
  11. Statin Toxicity · Natalie C. Ward · 2019 · 772 citations · Cited by this paper
  12. Cellular Senescence in Diabetic Cardiomyopathy: Mechanistic Insights and Therapeutic Perspectives · 2026 · Related
  13. PubChem's BioAssay Database · Y. Wang · 2011 · 681 citations · Cited by this paper
  14. Hyperuricemia and Hypoxic Pulmonary Hypertension: Pathogenic Links, Clinical Evidence, and Emerging Therapeutic Insights · 2026 · Related
  15. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity · Payel Roy · 2021 · 580 citations · Cited by this paper
  16. Aspirin Instead of Clopidogrel after Percutaneous Coronary Intervention in Atrial Fibrillation: More than just an Option · 2026 · Related
  17. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice · Frank L.J. Visseren · 2021 · 546 citations · Cited by this paper
  18. Possible clinical drug interactions between ticagrelor and concomitant medications: for adverse drug event monitoring in real-world · 2026 · Related
  19. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development · Anroop Balachandran Nair · 2018 · 477 citations · Cited by this paper
  20. Comparing the 2025 ESC/EAS Focused Update and the 2026 ACC/AHA Dyslipidemia Guideline: Convergences, Divergences, and Practical Implications · 2026 · Related
  21. Inflammation in atherosclerosis: pathophysiology and mechanisms · Amir Ajoolabady · 2024 · 430 citations · Cited by this paper
  22. Lysosomal Cysteine Proteases in Atherosclerosis · Jian Liu · 2004 · 391 citations · Cited by this paper
  23. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract · François Mach · 2018 · 387 citations · Cited by this paper
  24. Atherosclerotic Plaque Healing · Rocco Vergallo · 2020 · 385 citations · Cited by this paper
  25. Atherosclerosis · Peter Libby · 2016 · 321 citations · Cited by this paper
  26. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management · Om P. Ganda · 2018 · 197 citations · Cited by this paper
  27. Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies · Emma Andrade · 2016 · 187 citations · Cited by this paper
  28. Lentinan inhibits oxidative stress and alleviates LPS-induced inflammation and apoptosis of BMECs by activating the Nrf2 signaling pathway · Meijuan Meng · 2022 · 148 citations · Cited by this paper
  29. HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy · Man Chen · 2023 · 109 citations · Cited by this paper
  30. Hck Tyrosine Kinase Regulates TLR4-Induced TNF and IL-6 Production via AP-1 · Maria Smolinska · 2011 · 97 citations · Cited by this paper
  31. A Comprehensive Review of PCSK9 Inhibitors · Caroline Coppinger · 2022 · 97 citations · Cited by this paper
  32. Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK/NF-κB and Nrf2/HO-1 signaling pathway · Tianjiao Chu · 2024 · 97 citations · Cited by this paper
  33. Amino Acids and Their Metabolism in Atherosclerosis · Katrin Nitz · 2019 · 94 citations · Cited by this paper
  34. Inflammation in atherosclerosis: Lessons and therapeutic implications · Peter Libby · 2025 · 92 citations · Cited by this paper
  35. Residual cardiovascular risk: When should we treat it? · Francisco Gómez-Delgado · 2023 · 78 citations · Cited by this paper
  36. Natural deep eutectic solvents for the extraction of lentinan from shiitake mushroom: COSMO-RS screening and ANN-GA optimizing conditions · Dayuan Wang · 2023 · 74 citations · Cited by this paper
  37. Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis · Yajing Wei · 2023 · 71 citations · Cited by this paper
  38. METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis · Longbin Zheng · 2024 · 58 citations · Cited by this paper
  39. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota · Xin Zhao · 2020 · 46 citations · Cited by this paper

Source: OpenAlex (CC0)